Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma

Overview of attention for article published in Laboratory Investigation, August 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#45 of 3,280)
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

twitter: 4 X users
patent: 4 patents

Readers on

mendeley: 43 Mendeley

So far, Altmetric has seen 6 X posts from 4 X users, with an upper bound of 14,501 followers.

RT @epigen_papers: Pubmed: Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in… http…

Pubmed: Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in… http://t.co/US56Pqfwaf

RT @SurgeonRetina: Our new #biomarker for #retinoblastoma, #EZH2, also novel #epigenetics #target for the #cancer http://t.co/0jgMd5pW9R ht…

Our new #biomarker for #retinoblastoma, #EZH2, also novel #epigenetics #target for the #cancer http://t.co/0jgMd5pW9R http://t.co/5kmwiDhXsz

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.